Long-Term Outcomes of Fractionated Stereotactic Proton Therapy for Vestibular Schwannoma: A Case Series [0.03%]
分次立体定向质子治疗听神经瘤的长期结果：病例系列报告
Simeng Zhu,Ronny Rotondo,William M Mendenhall et al.
Simeng Zhu et al.
Purpose: Evaluate clinical outcomes in patients with vestibular schwannoma (VS) treated with fractionated proton therapy (PT) at a single institution. Mat...
Fractionated Proton Beam Therapy for Acoustic Neuromas: Tumor Control and Hearing Preservation [0.03%]
分次质子束治疗前庭神经鞘瘤的肿瘤控制与听力保护
Carolyn J Barnes,David A Bush,Roger I Grove et al.
Carolyn J Barnes et al.
Purpose: This prospective cohort evaluated patients with acoustic neuroma treated with proton irradiation at Loma Linda University Medical Center. A dose of 50.4 Gy in 28 fractions was given to improve hearing preservatio...
Proton Beam Therapy for Bronchogenic Adenoid Cystic Carcinoma: Dosimetry, Toxicities, and Outcomes [0.03%]
质子束治疗支气管腺囊性癌：剂量学、毒性和结果分析
Vivek Verma,Liyong Lin,Charles B Simone nd
Vivek Verma
Purpose: Bronchogenicadenoid cystic carcinoma (ACC) is a rare malignancy particularly challenging to irradiate, largely owing to anatomic location and associated toxicities. Proton beam therapy (PBT) can reduce doses to n...
Monika Puchalska,Thomas Tessonnier,Katia Parodi et al.
Monika Puchalska et al.
Purpose: Up to now, carbon ions have shown the most favorable physical and radiobiological properties for radiation therapy of, for example, deep-seated radioresistant tumors. However, when carbon ions penetrate matter, t...
An Anthropomorphic Head and Neck Quality Assurance Phantom for Credentialing of Intensity-Modulated Proton Therapy [0.03%]
一种用于质子调强治疗认证的人体头部和颈部质量保证体模
Daniela Branco,Paige Taylor,Xiaodong Zhang et al.
Daniela Branco et al.
Purpose: To design and commission a head and neck (H&N) anthropomorphic phantom that the Imaging and Radiation Oncology Core Houston (IROC-H) can use to verify the quality of intensity-modulated proton therapy H&N treatme...
Proton Therapy Reduces Normal Tissue Dose in Extended-Field Pelvic Radiation for Endometrial Cancer [0.03%]
扩大野子宫癌盆腔放射治疗中质子治疗可减少正常组织照射剂量
Melody J Xu,Alisha Maity,Jennifer Vogel et al.
Melody J Xu et al.
Purpose: We dosimetrically compared pencil beam scanning (PBS) proton therapy and intensity-modulated radiation therapy (IMRT) for pelvic and para-aortic lymph node disease in endometrial carcinoma and present acute toxic...
Evaluating Cardiac Biomarkers after Chemotherapy and Proton Therapy for Mediastinal Hodgkin Lymphoma [0.03%]
化疗和质子治疗后纵隔霍奇金淋巴瘤患者的心脏生物标志物评价
Lidia Guzhva,Nancy P Mendenhall,Christopher G Morris et al.
Lidia Guzhva et al.
Purpose: Late cardiac complications from thoracic radiation of patients with Hodgkin lymphoma are of great concern. The authors investigated whether cardiac biomarkers could identify patients with early cardiac damage fro...
Intensity-Modulated Proton Therapy Adaptive Planning for Patients with Oropharyngeal Cancer [0.03%]
咽癌患者强度调制质子治疗的适应性计划研究
Richard Y Wu,Amy Y Liu,Terence T Sio et al.
Richard Y Wu et al.
Purpose: The authors aimed to illustrate the potential dose differences to clinical target volumes (CTVs) and organs-at-risk (OARs) volumes after proton adaptive treatment planning was used. ...
Biological Model for Predicting Toxicity in Head and Neck Cancer Patients Receiving Proton Therapy [0.03%]
用于接受质子治疗的头颈部癌症患者的生物模型预测毒性作用
Croix C Fossum,Chris J Beltran,Thomas J Whitaker et al.
Croix C Fossum et al.
Purpose: To use a linear energy transfer (LET) dependent formula for relative biological effectiveness (RBE) to generate a biological model that can be used to predict toxicity in patients treated with proton therapy for ...